Andrew Fisher

Insider Reports History

Location
London
Signature
/s/ Andrew Fisher
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Fisher:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verona Pharma plc General Counsel Ordinary Shares 0 $0 $106.71 07 Oct 2025 Direct
Verona Pharma plc General Counsel Restricted Share Units 167,056 07 Jul 2025 Direct
Verona Pharma plc General Counsel Restricted Stock Units 146,168 01 Aug 2025 Direct
Verona Pharma plc General Counsel Restricted Share Unit 0 07 Oct 2025 Direct
Verona Pharma plc General Counsel Share Options (Right to Buy) 0 07 Oct 2025 Direct

Insider Reports Filed by Andrew Fisher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRNA Verona Pharma plc 07 Oct 2025 8 $0 4 General Counsel 08 Oct 2025, 16:45
VRNA Verona Pharma plc 01 Aug 2025 3 -$125,969 4 General Counsel 05 Aug 2025, 20:30
VRNA Verona Pharma plc 07 Jul 2025 4 -$451,519 4 General Counsel 09 Jul 2025, 18:38
VRNA Verona Pharma plc 16 Jun 2025 3 -$761,096 4 General Counsel 18 Jun 2025, 16:31
VRNA Verona Pharma plc 15 May 2025 2 +$160,904 4/A General Counsel 18 Jun 2025, 16:30
VRNA Verona Pharma plc 19 Mar 2025 5 -$234,127 4 General Counsel 01 May 2025, 20:59
VRNA Verona Pharma plc 30 Oct 2024 1 $0 4 General Counsel 01 Nov 2024, 19:13
VRNA Verona Pharma plc 01 Apr 2024 1 $0 4 General Counsel 02 Apr 2024, 16:15
VRNA Verona Pharma plc 04 Mar 2024 0 $0 3 General Counsel 07 Mar 2024, 21:40